FDAnews Drug Daily Bulletin

Pharma Blog Watch

June 6, 2006

Caps on Medicare Drug Benefits — the Downside (DrugWonks.com)
There are obvious negatives to capping costs for Medicare benefits, writes blogger Peter Pitts. In a concise and curt entry, Pitts cites a recent New England Journal of Medicine article detailing the financial and clinical outcomes of a price-capped study, and decries the causes of the study's largely unfavorable results.

Cancer Treatments and Drug Resistance (In the Pipeline)
What are the benefits and detriments of all the new cancer therapies that have emerged in recent years? Blogger Derek Lowe discusses oncology treatments, focusing on the issue of drug resistance, in his entry.

'Restless Brush Syndome' in recent RLS Advertising (Pharma Marketing Blog)
What's really involved in the advertising campaigns for Restless Legs Syndrome treatments, such as GlaxoSmithKline's Requip? In a humorous and subtly scathing entry, blogger John Mack muses about this issue.